-
EXPLORING THE POTENTIAL IMPACT OF THE INFLATION REDUCTION ACT’S PART D REDESIGN ON FORMULARY COVERAGE?IN COMPETITIVE CLASSES: 2024-2026
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT AND PAYER DECISION MAKING: A REVIEW OF POLICY AND GUIDANCE ACROSS EUROPE, CANADA, AND THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SUCCESSFUL USES OF REAL-WORLD EVIDENCE IN FDA LABEL UPDATES: A DESCRIPTIVE ANALYSIS OF REGULATORY TRENDS
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF EARLY PREGNANCY IDENTIFICATION AND VIRTUAL GAP CLOSURE ON HEDIS METRICS
Mar 18, 2026, 21:38 PM -
DRIVERS OF MOBILE PATIENT PORTAL APP USE: INSIGHTS FOR IMPLEMENTATION AND VALUE-BASED DECISION-MAKING
Mar 18, 2026, 21:38 PM -
COMPARING HEALTH, HEALTH AND WELLBEING (HWB), AND QUALITY OF LIFE (QOL) VISUAL ANALOGUE SCALE (VAS) CONSTRUCTS WITH THE EQ-HWB-9 IN THE UNITED STATES (US), UNITED KINGDOM (UK), AND GERMANY
Mar 18, 2026, 21:38 PM -
BONE MARROW BIOPSIES IN HEMATOLOGIC CANCERS: A SYSTEMATIC REVIEW OF PATIENT AND CAREGIVER BURDEN
Mar 18, 2026, 21:38 PM -
EVALUATING THE COST-EFFECTIVENESS OF PHARMACOGENETIC TESTING VIA THE MANTARA® PGX DNA TEST: INSIGHTS FROM NHS HEALTH CHECK INTEGRATION AND UK-BASED ECONOMIC MODELLING
Mar 18, 2026, 21:38 PM -
TRENDS IN PREECLAMPSIA PREVALENCE AND COMORBIDITY BURDEN AMONG PREGNANT WOMEN USING U.S. ADMINISTRATIVE CLAIMS DATA
Mar 18, 2026, 21:38 PM -
MIGRAINE BURDEN OF ILLNESS AMONG A COMMERCIALLY INSURED US POPULATION (IFORM-I)
Mar 18, 2026, 21:38 PM -
TIMING OF SERIOUS ADVERSE EVENTS FOLLOWING MIFEPRISTONE ABORTION IN US COMMERCIAL AND MEDICAID POPULATIONS
Mar 18, 2026, 21:38 PM -
ADAPTING AGENTIC LARGE LANGUAGE MODELS (ALLM) TRAINED IN SOLID TUMORS FOR SYSTEMATIC LITERATURE REVIEW (SLR) IN HEMATOLOGICAL MALIGNANCIES: VALIDATION IN MULTIPLE MYELOMA (MM) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF EXAGAMGLOGENE AUTOTEMCEL FOR PATIENTS WITH SICKLE CELL DISEASE AND RECURRENT VASO-OCCLUSIVE EVENTS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
INTEGRATING RCT AND RWD FOR LONG-TERM NEONATAL OUTCOME EVALUATION: LESSONS FROM THE PRIME STUDY
Mar 18, 2026, 21:38 PM -
EVOLUTION OF AI VALUE IN CHINESE CLINICAL PRACTICE: A 2025 SURVEY AND CASE SERIES ON PHYSICIAN-PRIORITIZED APPLICATIONS
Mar 18, 2026, 21:38 PM -
EXPLORING THE ASSOCIATION BETWEEN CAREGIVER QOL AND THE CARE PROVIDED TO ADULTS WITH SEVERE VISUAL IMPAIRMENT CAUSED BY RARE DISEASE
Mar 18, 2026, 21:38 PM -
EFFECT MODIFICATION BY MULTIMORBIDITY BURDEN ON THE EFFECTIVENESS AND SAFETY OF SGLT2 INHIBITORS IN OLDER ADULTS WITH T2D: A TARGET TRIAL EMULATION STUDY
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC LITERATURE REVIEW ON FINANCIAL BURDEN, FINANCIAL TOXICITY, OUTCOMES, POTENTIAL INTERVENTIONS, AND POLICIES ASSOCIATED WITH OUT-OF-POCKET MEDICATION AND HEALTHCARE EXPENSES AMONG OLDER PATIENTS IN THE US
Mar 18, 2026, 21:38 PM -
FROM MORTALITY TO MONEY: YEARS OF LIFE LOST AND THE ECONOMIC BURDEN OF CYSTIC FIBROSIS IN COLOMBIA (2005-2023)
Mar 18, 2026, 21:38 PM -
BRIDGING THE GAP: DEMOGRAPHIC REWEIGHTING OF REAL-WORLD SURVIVAL DATA VERSUS RCTS IN ACUTE MYELOID LEUKEMIA
Mar 18, 2026, 21:38 PM
